Now showing items 1-20 of 21

    • Prockop, Darwin J.; Oh, Joo Youn; Berkowitz, Barry; Roddy, Gavin W.; Rosa, Robert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-10-23)
      The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
    • Prockop, Darwin J.; Oh, Joo Youn; Roddy, Gavin W.; Rosa, Robert; Berkowitz, Barry A. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2014-07-22)
      The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
    • Prockop, Darwin J.; Oh, Joo Youn; Berkowitz, Barry (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-17)
      The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
    • Prockop, Darwin J.; Oh, Joo Youn; Berkowitz, Barry; Roddy, Gavin W.; Rosa, Robert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-08-15)
      The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
    • Safe, Stephen; Kim, Kyounghyun (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-02-17)
      Provided herein are methods directed to modulating the pro-oncogenic effects of noncoding RNAs (ncRNAs) through their interactions with specificity protein transcription factors (SpTFs). In one aspect, the disclosure ...
    • Sacchettini, James, C.; Miller, Matthew W.; Wallis, Deann; Zhou, Nian E.; Fossum, Theresa W. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-03-12)
      Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a rifamycin derivative or a pharmaceutically acceptable salt, ...
    • Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-09-15)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-01-16)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-10)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Kao, Cheng C.; Tharachaparamba, Ranjith Kumar (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2011-11-29)
      The invention relates to compositions and methods related to Toll-like receptor (TLR) polypeptides. In some embodiments, the invention relates to managing TLR3 related diseases. In further embodiments, the invention relates ...
    • Zingaro, Ralph A.; Zingaro, Ralph A. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-07-17)
      The present invention provides organic arsenicals which may be used to treat numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.
    • Mckenzie, Scott K.; Giletto, Anthony; Hitchens, Duncan G.; Hargis, Billy M.; Herron, Kelly L. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2003-02-11)
      The present invention provides a method for controlling microbial populations in the gastrointestinal tract of animals. The method comprises the step of orally administering an effective amount of a peracid to an animal. ...
    • Safe, Stephen H. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2000-10-24)
      Methods and pharmaceutical combinations for inhibiting estrogen-dependent tumors via the co-administration of antiestrogen triphenylethylenes, including tamoxifen, and alkyl PCDFs.
    • Freundlich, Joel S.; Sacchettini, James C.; Kriger, Inna V.; Ioerger, Thomas R.; Gawandi, Vijay (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2014-03-04)
      The present invention provides aryl- or heteroaryl-diketo acid compounds effective to inhibit an activity of a Mycobacterial malate synthase enzyme or to inhibit a malate synthase activity in other bacteria having the ...
    • Tsai, Robert Y.; Lin, Tao (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-11-15)
      In some embodiments, the present invention provides methods of treating a tumor in a subject. In some embodiments, the methods may include a step of administering to the subject a therapeutic composition that comprises: ...
    • Smith, James L.; Pruett, Stephen; Austin, Frank; Lu, Shien; Akshaya, Ravichandran; Laihing, Steven (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-04-23)
      Disclosed are occidiofungin formulations and uses thereof for the treatment of proliferative disorders, such as cancer. Methods of producing the disclosed occidiofungin formulations are also provided. Further, methods of ...
    • Bix, Gregory J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-07-07)
      The disclosed invention relates to the use of perlecan domain V (DV) for the treatment of stroke, traumatic brain injury (TBI) or spinal cord injuries (SCI). In certain embodiments, fusion proteins of DV can be used for ...
    • Schetz, John A.; Hoger, Sally A. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-11-24)
      A group of antimicrobial compounds shows effectiveness for preventing bacterial growth and bio film formation. In particular, the compounds are effective for preventing the growth of gram-positive bacteria, including ...
    • Hillman, Jeffrey D.; Smith, James Leif; Wilson-stanford, Shawanda R. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-02-16)
      The invention provides recombinant Streptococcus mutans strains that can be used to improve oral health. An embodiment of the invention provides a method of reducing the incidence or severity of dental caries in a dental ...
    • Bix, Gregory J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-06-18)
      The present invention is drawn to methods of stimulating or enhancing angiogenesis in a patient comprising, administering to said patient a therapeutically effective amount of an endorepellin protein, wherein said endorepellin ...